Novartis hopes to commercialise "smart lens" within 5 years
ZURICH (Reuters) - Novartis (NOVN.VX) expects the "smart lens" technology it has licensed from Google (GOOGL.O) will take several years to develop, but hopes to have a product ready for market in about five years, the drugmaker's chief executive said on Tuesday.
"This isn't going to happen overnight because it's a breakthrough technology. It's not months, we're probably talking about years. We would hope to be able to commercialise within about five years," Joe Jimenez told Reuters in an interview.
Novartis said earlier on Tuesday it had struck an agreement with Google (GOOGL.O) to develop "smart lens" technology for medical use in the eye.
(Reporting by Caroline Copley and Paul Arnold.)
- Tweet this
- Share this
- Digg this
Alibaba Group Holding Ltd's shares surged in their first day of trading as investors jumped at the chance to get in on what looks likely to be the largest IPO in history and profit from China's growing middle class. Article
Los Angeles iPad rollout for schools slowed by technical challenges - report. Full Article
When music stops for Oracle CEO dance, Catz may grab Ellison's chair - analysts. Full Article